Ozempic®
Semaglutide · GLP-1 Injection
Weekly GLP-1 injection — a trusted option used globally for blood-sugar and appetite control.
Ozempic® (semaglutide) is a once-weekly injection originally licensed to improve blood-sugar control in adults with type 2 diabetes. Because GLP-1 also regulates appetite and gastric emptying, many patients experience meaningful weight reduction as a clinical benefit. Our UK prescribers will assess whether Ozempic is appropriate for your profile or whether Wegovy — the weight-management dose of the same molecule — is a better fit.
- Active ingredient
- Semaglutide
- Format
- Pre-filled multi-dose pen
- Frequency
- Once weekly
- Prescription
- Required
Benefits
Why patients choose Ozempic®.
Proven molecule
Semaglutide is the most-studied GLP-1 in recent weight-management literature.
Once weekly
Simple weekly routine — no daily pills to remember.
Broader metabolic support
Often improves HbA1c, blood pressure and lipid markers alongside weight change.
Clinician-reviewed
Our prescribers confirm suitability and personalise dose titration.
How it works
A simple, evidence-based approach.
- 1
Inject subcutaneously once a week into the thigh, abdomen or upper arm.
- 2
Semaglutide activates GLP-1 receptors — reducing appetite and slowing digestion.
- 3
Start at 0.25 mg weekly and step up every 4 weeks up to 1 mg or 2 mg depending on tolerance and response.
- 4
Most effective when paired with a healthier eating pattern and regular activity.
Choose your dose
Prescription-only medicine. Every order is reviewed by a UK-registered prescriber before dispatch.
Questions
Ozempic® FAQs
Everything you need to know before starting your course.
Alternatives
